Thema: CA6823108759
ONCY, CA6823108759
euro-2387086_1920.jpg - Foto: THN
Oncolytics Biotech stock: GOBLET data show durable anal-cancer responses
Oncolytics Biotech stock gains a new clinical data point from its GOBLET study in previously treated anal cancer. The company is pursuing a regulatory path.
ad-hoc-news.de, heute 03:06 Uhr
ONCY, CA6823108759
Oncolytics Biotech stock: GOBLET data report 15-month response ...
